Drug intelligence / Profile preview

sodium desoxyribonucleate

Development stage
Phase 3
Lead developer
Tekhnomedservis
Modality
Small Molecules
Administration
Intranasal, Intramuscular, Topical
01

Overview

**Sodium desoxyribonucleate** (also called sodium deoxyribonucleate) is a pharmaceutical immunomodulator and tissue regenerant, often marketed under the brand name Derinat. It consists of low molecular weight native fragments of deoxyribonucleic acid (DNA) as sodium salts. Mechanistically, sodium desoxyribonucleate acts primarily as an immunomodulator—stimulating B cells, activating helper T cells (Th cells), and promoting increased secretory IgA (sIgA) levels. It demonstrates regenerative (tissue reparative) properties, enhances anti-infectious protection by boosting local and systemic immunity, and normalizes hematopoiesis (formation of blood cellular elements). Sodium desoxyribonucleate also functions as a powerful antioxidant and is being studied for its ability to protect against ischemic damage and accelerate hematopoietic recovery after radiation or polytrauma. It is primarily indicated for prevention and treatment of acute respiratory infections, severe associated injury (polytrauma), and has investigational use in improving outcomes following stem cell transplantation and in conditions such as chronic hepatitis, leukopenia, thrombocytopenia, and aplastic anemia[1][2][3][5][6][7].

Brand names
Derinat
Other names
sodium deoxyribonucleatesodium desoxyribonucleateSD
02

Targets

TLR9 (Toll-like receptor 9)

Beyond the preview

Go deeper on sodium desoxyribonucleate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium desoxyribonucleate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call